Skip to content

Shattuck Labs, Inc. STTK Operating lease liabilities

Operating lease liabilities at other companies

Vor Biopharma logo
Vor BiopharmaVOR
MoonLake Immunotherapeutics logo
MoonLake ImmunotherapeuticsMLTX
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
Upstream Bio, Inc. logo
Upstream Bio, Inc.UPB
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
Alumis Inc. logo
Alumis Inc.ALMS

Other financials

Income statement

See full
Revenue-
Operating income-$15.5M-8.0%
Net income-$14.8M-7.8%
EPS (diluted)-$0.13+51.9%

Balance sheet

See full
Cash & equivalents$90.4M+48.5%
Total debt$2.9M-9.5%
Total equity$95.8M+41.8%
Total assets$102.1M+32.3%

Cash flow

See full
Operating cash flow-$13.4M-11.6%
CapEx$63.0K
Free cash flow-$13.5M-12.1%

Valuation

See full
Market cap$564.45M+1,131%
Enterprise value$476.92M-4,119%
P/S564.5×+554×

Profitability

See full
Operating margin-5,266.4%-9,520pp
Net margin-4,987.4%-8,966pp
FCF margin-4,140.8%-7,144pp

Returns & leverage

See full
Return on equity-61%-8.0pp
Debt / equity0.0×
Current ratio22.1×+13.0×

Where this comes from

Reported directly by Shattuck Labs, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: Shattuck Labs, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Shattuck Labs, Inc.'s operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Shattuck Labs, Inc.'s operating lease liabilities?
Shattuck Labs, Inc. (STTK) reported operating lease liabilities of -$225K in Q1 2026.
How has Shattuck Labs, Inc.'s operating lease liabilities changed year-over-year?
Shattuck Labs, Inc.'s operating lease liabilities increased by 6.3% year-over-year, from -$240K to -$225K.